4.6 Article

A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma

Kanwal Raghav et al.

Summary: The AtezoBev combination therapy showed promising and durable efficacy in patients with advanced MPeM, addressing a significant unmet need for this rare disease. Biomarker analyses highlighted epithelial-mesenchymal transition phenotype as a key resistance mechanism, demonstrating the value of translational clinical trials in rare tumors.

CANCER DISCOVERY (2021)

Article Pathology

Malignant Diffuse Mesothelioma in Women A Study of 354 Cases

Elizabeth N. Pavlisko et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Article Gastroenterology & Hepatology

Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma

Yufei Liang et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2019)

Article Medical Laboratory Technology

Immunohistochemistry in Peritoneal Mesothelioma A Single-Center Experience of 244 Cases

Radhika Theresa Tandon et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2018)

Article Oncology

Analysis of prognostic factors of patients with malignant peritoneal mesothelioma

Wenjie Yin et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)

Review Oncology

Malignant peritoneal mesothelioma: a review

Glenn Broeckx et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2018)